Potential Antidote to Vascular Disease Identified

by Kathy Jones on  June 5, 2011 at 1:05 AM Research News
RSS Email Print This Page Comment
Font : A-A+

The reason why the normally transient inflammatory response is not turned off and becomes chronic, secreting a signal molecule that promotes atherosclerosis has been revealed in a new study.
 Potential Antidote to Vascular Disease Identified
Potential Antidote to Vascular Disease Identified

The persistence of the inflammatory reaction is due to a loss of control over the activity of the immune system. So-called dendritic cells are known to play a central role in the adaptive immune response, functioning as activators of other classes of immune cells.

Now, an international team of researchers led by Professor Christian Weber of Ludwig-Maximilians-University (LMU) Munich and Privatdozentin Alma Zernecke of Würzburg University has demonstrated that dendritic cells release the chemokine CCL17 as a signal molecule, which inhibits a feedback mechanism that normally limits the activity of the immune system.

The new study has also identified a potential antidote to the signal molecule. As Professor Weber reports, "We were able to prevent the progression of atherosclerosis using an antibody raised against CCL17."

In other words, CCL17 offers a promising starting point for the development of new therapeutic strategies.

Source: ANI

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive